Smoking Cessation Among US Adult Smokers With and Without Chronic Obstructive Pulmonary Disease, 2018

被引:17
|
作者
Liu, Yong [1 ]
Greenlund, Kurt J. [1 ]
VanFrank, Brenna [2 ]
Xu, Fang [1 ]
Lu, Hua [1 ]
Croft, Janet B. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Populat Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway Northeast,MS S-107-6, Atlanta, GA 30341 USA
[2] Ctr Dis Control & Prevent, Off Smoking & Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA
关键词
TOBACCO PRODUCT USE; UNITED-STATES; THORACIC SOCIETY; AMERICAN-COLLEGE; CHEST PHYSICIANS; COPD; RISK;
D O I
10.1016/j.amepre.2021.12.001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: More than 3 of 5 U.S. adults who have ever smoked cigarettes have quit. This study assesses the latest estimates of smoking cessation among U.S. adults with and without chronic obstructive pulmonary disease who have ever smoked cigarettes (ever smokers). Methods: Data from 161,233 ever smokers (12.8% with chronic obstructive pulmonary disease) in the 2018 Behavioral Risk Factor Surveillance System were analyzed in 2020. Weighted percentages of quit ratios (percentage of ever smokers who quit smoking), past-year quit attempts (>= 1 day), and recent successful cessation (quit >= 6 months ago) by self-reported physician-diagnosed chronic obstructive pulmonary disease status were obtained from multivariable logistic regression analyses, with adjustment for sociodemographic characteristics, health risk behaviors, depression, and asthma. Results: Adults with chronic obstructive pulmonary disease who smoked had greater age-adjusted past-year quit attempts (68.8% vs 64.3%) but lower recent successful cessation (4.5% vs 5.8%) and quit ratio (53.2% vs 63.9%) than those without chronic obstructive pulmonary disease. After adjusting for covariates, adults with chronic obstructive pulmonary disease who smoked had a significantly higher percentage of past-year quit attempts but similar recent successful cessation and a significantly lower lifetime quit ratio than their counterparts without chronic obstructive pulmonary disease. Conclusions: These findings suggest that individuals with chronic obstructive pulmonary disease who try to quit smoking may be less likely to succeed than those without chronic obstructive pulmonary disease. Evidence-based treatments for smoking cessation remain an important component of a comprehensive approach to helping all adults to quit and are a particularly important element of chronic obstructive pulmonary disease management and care. Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.
引用
收藏
页码:492 / 502
页数:11
相关论文
共 50 条
  • [41] Differences in cessation attempts and cessation methods by race/ethnicity among US adult smokers, 2016-2018
    Lee, Juhan
    Avila, Jaqueline Contrera
    Ahluwalia, Jasjit S.
    [J]. ADDICTIVE BEHAVIORS, 2023, 137
  • [42] Smoking cessation care received by veterans with chronic obstructive pulmonary disease (COPD).
    Sherman, SE
    Lanto, AB
    Nield, M
    Yano, E
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 296 - 296
  • [43] Benefits and Risks of Pharmacological Smoking Cessation Therapies in Chronic Obstructive Pulmonary Disease
    Edwin J. Wagen
    Maurice P.A. Zeegers
    Constant P. van Schayck
    Emiel F.M. Wouters
    [J]. Drug Safety, 2003, 26 : 381 - 403
  • [44] The effectiveness of individual interventions on smoking cessation of chronic obstructive pulmonary disease patients
    Sharifpour, Ali
    Taghizadeh, Fatemeh
    Zarghami, Mehran
    Alipour, Abbas
    [J]. JOURNAL OF NURSING AND MIDWIFERY SCIENCES, 2020, 7 (01) : 13 - 21
  • [45] What are the Barriers of Chronic Obstructive Pulmonary Disease (COPD) Patients in Smoking Cessation?
    Ozkarafakili, Mufide Arzu
    Yangin, Metin
    Albayrak, Gulhan Ayhan
    Bardakci, Mustafa Ilteris
    [J]. MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2024, 58 (02): : 179 - 188
  • [46] Association of low income with pulmonary disease progression in smokers with and without chronic obstructive pulmonary disease
    Lowe, Katherine E.
    Make, Barry J.
    Crapo, James D.
    Kinney, Gregory L.
    Hokanson, John E.
    Kim, Victor
    Iyer, Anand S.
    Bhatt, Surya P.
    Hoth, Karin F.
    Holm, Kristen E.
    Wise, Robert
    Demeo, Dawn
    Foreman, Marilyn G.
    Stone, Thomas J.
    Regan, Elizabeth A.
    [J]. ERJ OPEN RESEARCH, 2018, 4 (04)
  • [47] Smoking Cessation Clinics as an Aid for Early Diagnosis of Chronic Obstructive Pulmonary Disease
    Diez Pina, Juan Manuel
    Quilez Ruiz-Rico, Natividad
    Bilbao-Goyoaga Arenas, Teresa
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2015, 51 (09): : 470 - 470
  • [48] Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease
    Wagena, EJ
    Zeegers, MPA
    van Schayck, CP
    Wouters, EFM
    [J]. DRUG SAFETY, 2003, 26 (06) : 381 - 403
  • [49] Fully financed smoking cessation for patients with chronic obstructive pulmonary disease (COPD)
    Loth, Franziska
    Muhlig, Stephan
    Bickhardt, Jakob
    Heindl, Thomas
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [50] Inflammatory parameters and pulmonary biomarkers in smokers with and without chronic obstructive pulmonary disease (COPD)
    Andreeva, Elena
    Pokhasnikova, Marina
    Lebedev, Anatoly
    Moiseeva, Irina
    Kozlov, Anton
    Kuznetsova, Olga
    Degryse, Jean-Marie
    [J]. JOURNAL OF THORACIC DISEASE, 2021, 13 (08) : 4812 - +